Navigation Links
Novartis Consumer Health Inc. Issues Voluntary Nationwide Recall of Certain Over-the-Counter Products Due to Potential Presence of Foreign Tablets or Chipped or Broken Tablets or Gelcaps
Date:1/8/2012

00672065138

0067206513

 100007330

Bufferin® Extra Strength Tablets 39CT 

300672065391

10300672065398

0067206539

 100007776

Bufferin® Low Dose Tablets 130CT

300676424132

10300676424139

0067642413

 100007345

Bufferin® Regular Strength Tablets 130CT 

300672063137

10300672063134

0067206313

 100008631

Excedrin® Back & Body Caplets 100CT Account Specific

300676238920

10300676238927

0067623891

 100008076

Excedrin® Back & Body Caplets 100CT Account Specific No Carton

300676238944

10300676238941

0067623894

 100008075

Excedrin® Back & Body Caplets 100CT New Label

300676238913

10300676238910

0067623891

 100008073

Excedrin® Back & Body Caplets 24CT New Label

300676238241

10300676238248

0067623824

 100008074

Excedrin® Back & Body Caplets 50CT New Label

300676238500

10300676238507

0067623850

 100008627

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000927

10300672000924

0067200091

 100005995

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000941

10300672000948

0067200094

 100008027

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000941

10300672000948

0067200094

 100008026

Excedrin® Extra Strength Caplets 100CT Account Specific

300672000910

10300672000917

0067200091

 100003160

Excedrin&
'/>"/>

SOURCE Novartis Consumer Health, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

Related medicine technology :

1. Two Novartis Phase III Studies Show Twice as Many Ph+ CML Patients Achieve Deeper Levels of Response With Tasigna® Compared to Gleevec®
2. New Data Confirms Novartis Drug Afinitor® Significantly Extends Time Women With Advanced Breast Cancer Live Without Tumor Growth
3. Novartis Study Shows QTI571 Significantly Improved Walking Distance in Patients with Life-Threatening Pulmonary Arterial Hypertension
4. Novartis Drug Afinitor® Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
5. Novartis Study Showed ACZ885 Provided Substantial Symptom Relief in 84% of Patients With the Most Serious Form of Childhood Arthritis
6. Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
7. Novartis Drug Gleevec® Shows Significant Overall Survival Benefit for Patients With GIST After Three Years of Adjuvant Treatment vs. One Year
8. Novartis highlights extensive data on numerous compounds at ASCO in multiple cancers, including Phase III studies in GIST and myelofibrosis
9. Novartis Data Shows ACZ885 for Severe Gouty Arthritis Provided Better Pain Relief and Reduced Risk of New Attacks by Up to 68% vs. Steroid
10. FDA Approves Novartis Drug Afinitor to Treat Pancreatic Neuroendocrine Tumors
11. Novartis Gains FDA Approval for Afinitor® as First New Treatment in Nearly Three Decades for Patients with Advanced Pancreatic NET
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... Oct. 21, 2014   BioNano Genomics , ... genomics research centers to purchase an Irys™ System ... National Cancer Institute (NCI), NIH Intramural Sequencing Center (NISC) ... Irys, obtaining a comprehensive view of a genome ... (NGS) does not deliver the scalability or reliability ...
(Date:10/22/2014)... WESTMINSTER, Colo. , Oct. 22, 2014   ... class of infusion systems designed to maximize targeted delivery ... is pleased to announce that oncologist John R. ... Norris Comprehensive Cancer Center, and surgical oncologist Steven ... Center have joined the Company,s Scientific Advisory Board (SAB).  ...
Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3Surefire Medical's Scientific Advisory Board Expands, Broadens Clinical Trial Expertise 2
... /PRNewswire/ -- A new study suggests,strong variation in ... U.S. Anaphylaxis is a severe allergic,reaction that can ... differences in EpiPen prescribing, a marker of,anaphylaxis risk, ... low levels of vitamin D,from lack of sunshine, ...
... Journal of the,American Society of Clinical Oncology has ... by Dr. Siu-Fun Wong, and her,colleagues, which concluded ... reduction in the pain and,itching of a rash ... as EGFR inhibitors. This ongoing supportive care trial ...
Cached Medicine Technology:Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2Clinical Study Shows Regenecare Relieves Pain and Itching of Skin,Rashes Caused by Widely Used Cancer Drugs 2
(Date:10/25/2014)... New York, New York (PRWEB) October 25, 2014 ... lawsuits ( http://www.thexareltolawsuit.com/ ) will be addressed in December, ... convenes its next hearing session. According to a Hearing ... Oral Arguments on the matter will be heard on ... Session will begin at 9:30 a.m. (In Re: Xarelto ...
(Date:10/25/2014)... Madison, WI (PRWEB) October 25, 2014 ... of tax-advantaged medical and other benefits account management ... designed to help employers save on taxes, reduce ... new Suites provide tax savings and the efficient ... can pick the Suite that best meets their ...
(Date:10/25/2014)... (PRWEB) October 25, 2014 The ... ( http://www.vaginalmeshlawsuit2015.com/ ) filed against Boston Scientific ... U.S. District Court, Southern District of West Virginia ... on Punitive Damages in a group of cases ... ruling issued on October 21st, U.S. District Judge ...
(Date:10/25/2014)... -- Not getting the right amount of sleep might ... suggests. Those who sleep less or more than ... be more prone to developing the chronic condition, which ... authors concluded that duration and quality of sleep are ... bowel diseases. "Both short and long durations of ...
(Date:10/25/2014)... 2014 (HealthDay News) -- October,s shorter, darker days can ... disorder, according to an expert. People affected ... overly tired, lack motivation and even have trouble getting ... to suicide, said Dr. Angelos Halaris, a professor in ... University Chicago Stitch School of Medicine. "Seasonal affective ...
Breaking Medicine News(10 mins):Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 2Health News:Xarelto Lawsuit News: JPML to Hear Oral Arguments on Proposed Xarelto Multidistrict Litigation at December Hearing, Bernstein Liebhard LLP Reports 3Health News:TASC’s New Suites Offer Tax Savings and Protection 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 2Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 3Health News:Transvaginal Mesh Lawsuits Move Forward, As Federal Judge Denies Motion for Summary Judgment on Punitive Damages in Florida Cases, Bernstein Liebhard LLP Reports 4Health News:Sleep Duration Linked to Ulcerative Colitis Risk in Study 2Health News:Dark Days Here for Folks With Seasonal Depression 2
... Successful, OWINGS MILLS, Md., Oct. 4 Medifast, ... the current business outlook, the,Company is updating full year ... expects to report revenue of $81 to $83 million ... Previously, the Company,expected to report revenue of $85 to ...
... just part of what is ... local nonprofit for teens., WILSONVILLE, Ore., Oct. 4 On Tuesday, ... in furniture,arcade games and supplies. These and other items, unused for at ... to the,Sexual Minority Youth Resource Center (SMYRC). Volunteer crews will move ...
... - A new American Heart,Association survey (1) shows consumer awareness of the ... high. But consumers still need,some key information to improve how they eat., ... Fats Are The survey shows that:, --While 92 percent of ... jump from 84 percent in 2006 - only 21 percent can name ...
... revealing how toxic chemicals disrupt gene activity and other ... -- and why some individuals are particularly vulnerable. For ... more likely to experience side effects from certain medications, ... , How can this type of research -- known ...
... 22 new centers now added, first participants set to join ... -- The largest study ever of the impact of environment ... directed from 22 new centers across the United States, organizers ... first participants enrolled in the National Children,s Study should be ...
... president and CCO of,KickSkirt, Inc., will lead a ... the health of their children while also improving ... The Marketing-To-Moms Conference,October 23-24, 2007, Chicago Cultural Center. ... and medical director of Peak Wellness and star ...
Cached Medicine News:Health News:Medifast Announces Updated Full Year 2007 Guidance 2Health News:Medifast Announces Updated Full Year 2007 Guidance 3Health News:Medifast Announces Updated Full Year 2007 Guidance 4Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 2Health News:Contents of the McGinnis Mansion Refurbishes Portland, Oregon Sexual Minority Youth Center 3Health News:Americans' Knowledge of Fats Growing But Still Insufficient 2Health News:Americans' Knowledge of Fats Growing But Still Insufficient 3Health News:Largest Study of U.S. Children Readies for Launch 2Health News:Brands Tackle the Childhood Obesity Issue During M2Moms(TM) - The Marketing-To-Moms Conference 2
... lightweight self-adhesive insulin pod that you fill with ... up to three days and then replace. The ... your body through a small flexible tube (called ... into its wireless companion, the Personal Diabetes Manager. ...
The MiniMed Paradigm REAL-Time System is the world's first system to integrate an insulin pump with REAL-Time continuous glucose monitoring, taking diabetes management to a level you just can't achie...
The IR 1000 Insulin Infusion Pump from Animas offers unprecedented safety features, performance, and convenience....
... premium product for acne, XtremeClear, powered ... on a scalable multi-application platform. A ... acne, XtremeClear works fast, providing noticeable ... treatments. Uncompromising safety in each of ...
Medicine Products: